全文获取类型
收费全文 | 73492篇 |
免费 | 6001篇 |
国内免费 | 4188篇 |
专业分类
耳鼻咽喉 | 974篇 |
儿科学 | 752篇 |
妇产科学 | 537篇 |
基础医学 | 7757篇 |
口腔科学 | 1111篇 |
临床医学 | 7451篇 |
内科学 | 9693篇 |
皮肤病学 | 991篇 |
神经病学 | 3390篇 |
特种医学 | 3599篇 |
外国民族医学 | 8篇 |
外科学 | 9749篇 |
综合类 | 13643篇 |
现状与发展 | 14篇 |
一般理论 | 5篇 |
预防医学 | 5385篇 |
眼科学 | 1378篇 |
药学 | 7422篇 |
57篇 | |
中国医学 | 4222篇 |
肿瘤学 | 5543篇 |
出版年
2024年 | 162篇 |
2023年 | 734篇 |
2022年 | 1927篇 |
2021年 | 2763篇 |
2020年 | 2105篇 |
2019年 | 1824篇 |
2018年 | 1966篇 |
2017年 | 2047篇 |
2016年 | 2152篇 |
2015年 | 3327篇 |
2014年 | 4209篇 |
2013年 | 4608篇 |
2012年 | 6698篇 |
2011年 | 6879篇 |
2010年 | 5367篇 |
2009年 | 4567篇 |
2008年 | 5074篇 |
2007年 | 4898篇 |
2006年 | 4471篇 |
2005年 | 3778篇 |
2004年 | 2915篇 |
2003年 | 2830篇 |
2002年 | 2516篇 |
2001年 | 1736篇 |
2000年 | 1136篇 |
1999年 | 703篇 |
1998年 | 405篇 |
1997年 | 409篇 |
1996年 | 296篇 |
1995年 | 227篇 |
1994年 | 183篇 |
1993年 | 107篇 |
1992年 | 101篇 |
1991年 | 109篇 |
1990年 | 68篇 |
1989年 | 61篇 |
1988年 | 53篇 |
1987年 | 49篇 |
1986年 | 38篇 |
1985年 | 37篇 |
1984年 | 14篇 |
1983年 | 17篇 |
1982年 | 16篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 13篇 |
1978年 | 11篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1973年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Jae Hwang Song Chan Kang Deuk Soo Hwang Dong Hun Kang Yong Hwan Kim 《Foot and Ankle Surgery》2019,25(6):748-754
BackgroundThe purpose of this study was to investigate and compare the clinical outcomes of dorsal suspension with those of neurectomy for the treatment of Morton’s neuroma.MethodsWe conducted a retrospective study of dorsal suspension and neurectomy group. The dorsal suspension was performed by dorsal transposition of neuroma over the dorsal transverse ligament after neurolysis. The visual analog scale (VAS), the Foot and Ankle Ability Measure (FAAM), postoperative satisfaction, and complications were evaluated.ResultsBoth groups reported significant pain relief, and there were no significant differences between the groups with respect to postoperative pain. The postoperative FAAM outcomes showed no significant between-group differences. Satisfaction analysis showed ‘excellent’ and ‘good’ results in the dorsal suspension and neurectomy groups (95% and 77.7%, respectively). Complications of numbness and paresthesia reported in the dorsal suspension group (5% and 5%, respectively) were significantly fewer than those of neurectomy group (61.1% and 33.3%, respectively) (both, p < .05).ConclusionsWith its favorable results, dorsal suspension can be another operative option for the treatment of Morton’s neuroma.Level of Evidence: Level III, retrospective comparative case series. 相似文献
4.
Tian-Yuan Xiong Fang-Yang Huang Qi Liu Yong Peng Yuan-Ning Xu Jia-Fu Wei 《Annals of medicine》2020,52(7):361-366
Abstract
Background
Comorbidities are commonly seen in patients with coronavirus disease 2019 (COVID-19), but the clinical implication is not yet well-delineated. We aim to characterize the prevalence and clinical implications of comorbidities in patients with COVID-19. 相似文献5.
Xue Yao Yan Zhang Jian Hao Hui-Quan Duan Chen-Xi Zhao Chao Sun Bo Li Bao-You Fan Xu Wang Wen-Xiang Li Xuan-Hao Fu Yong Hu Chang Liu Xiao-Hong Kong Shi-Qing Feng 《中国神经再生研究》2019,(3)
Ferroptosis is an iron-dependent novel cell death pathway. Deferoxamine, a ferroptosis inhibitor, has been reported to promote spinal cord injury repair. It has yet to be clarified whether ferroptosis inhibition represents the mechanism of action of Deferoxamine on spinal cord injury recovery. A rat model of Deferoxamine at thoracic 10 segment was established using a modified Allen's method. Ninety 8-week-old female Wistar rats were used. Rats in the Deferoxamine group were intraperitoneally injected with 100 mg/kg Deferoxamine 30 minutes before injury. Simultaneously, the Sham and Deferoxamine groups served as controls. Drug administration was conducted for 7 consecutive days. The results were as follows:(1) Electron microscopy revealed shrunken mitochondria in the spinal cord injury group.(2) The Basso, Beattie and Bresnahan locomotor rating score showed that recovery of the hindlimb was remarkably better in the Deferoxamine group than in the spinal cord injury group.(3) The iron concentration was lower in the Deferoxamine group than in the spinal cord injury group after injury.(4) Western blot assay revealed that, compared with the spinal cord injury group, GPX4, xCT, and glutathione expression was markedly increased in the Deferoxamine group.(5) Real-time polymerase chain reaction revealed that, compared with the Deferoxamine group, mRNA levels of ferroptosis-related genes Acyl-CoA synthetase family member 2(ACSF2) and iron-responsive element-binding protein 2(IREB2) were up-regulated in the Deferoxamine group.(6) Deferoxamine increased survival of neurons and inhibited gliosis. These findings confirm that Deferoxamine can repair spinal cord injury by inhibiting ferroptosis. Targeting ferroptosis is therefore a promising therapeutic approach for spinal cord injury. 相似文献
6.
7.
8.
10.
Membrane trafficking processes are presumably vital for axonal regeneration after injury, but mechanistic understanding in this regard has been sparse. A recent loss-of-function screen had been carried out for factors important for axonal regeneration by cultured cortical neurons and the results suggested that the activity of a number of Rab GTPases might act to restrict axonal regeneration. A loss of Rab27b, in particular, is shown to enhance axonal regeneration in vitro, as well as in C. elegans and mouse central nervous system injury models in vivo. Possible mechanisms underlying this new finding, which has important academic and translational implication, are discussed. 相似文献